Compositions and methods for short interfering nucleic acid inhibition of NAv1.8
    1.
    发明申请
    Compositions and methods for short interfering nucleic acid inhibition of NAv1.8 有权
    NAv1.8短干扰核酸抑制的组成和方法

    公开(公告)号:US20060199779A1

    公开(公告)日:2006-09-07

    申请号:US11259588

    申请日:2005-10-26

    IPC分类号: A61K48/00 C07H21/02

    摘要: The invention provides short interfering nucleic acids, either single-stranded or double-stranded, that cause RNAi-induced degradation of mRNA from the Nav1.8 sodium channel gene; to pharmaceutical compositions comprising such short interfering nucleic acids; recombinant vectors comprising such short interfering nucleic acids; a method for inhibiting translation of an mRNA; a method for inhibiting expression of a polypeptide; a method for blocking the membrane potential in a cell; a method for blocking the sodium current in a cell; and a method for inhibiting chronic pain.

    摘要翻译: 本发明提供短干扰核酸,单链或双链,其引起RNAi诱导的来自Na + 1.8钠通道基因的mRNA的降解; 涉及包含这种短干扰核酸的药物组合物; 包含这种短干扰核酸的重组载体; 抑制mRNA翻译的方法; 抑制多肽表达的方法; 阻断细胞膜电位的方法; 阻止细胞中钠电流的方法; 和抑制慢性疼痛的方法。

    COMPOSITIONS AND METHODS FOR SHORT INTERFERING NUCLEIC ACID INHIBITION OF NAV1.8
    2.
    发明申请
    COMPOSITIONS AND METHODS FOR SHORT INTERFERING NUCLEIC ACID INHIBITION OF NAV1.8 有权
    短期干扰NAV1.8的核酸抑制剂的组合物和方法

    公开(公告)号:US20100305192A1

    公开(公告)日:2010-12-02

    申请号:US12789564

    申请日:2010-05-28

    摘要: The invention provides short interfering nucleic acids, either single-stranded or double-stranded, that cause RNAi-induced degradation of mRNA from the Nav1.8 sodium channel gene; to pharmaceutical compositions comprising such short interfering nucleic acids; recombinant vectors comprising such short interfering nucleic acids; a method for inhibiting translation of an mRNA; a method for inhibiting expression of a polypeptide; a method for blocking the membrane potential in a cell; a method for blocking the sodium current in a cell; and a method for inhibiting chronic pain.

    摘要翻译: 本发明提供短链干扰核酸,单链或双链,其导致RNAi诱导的来自Nav1.8钠通道基因的mRNA降解; 涉及包含这种短干扰核酸的药物组合物; 包含这种短干扰核酸的重组载体; 抑制mRNA翻译的方法; 抑制多肽表达的方法; 阻断细胞膜电位的方法; 阻止细胞中钠电流的方法; 和抑制慢性疼痛的方法。

    Compositions and methods for short interfering nucleic acid inhibition of Nav1.8
    3.
    发明授权
    Compositions and methods for short interfering nucleic acid inhibition of Nav1.8 有权
    Nav1.8短干扰核酸抑制的组成和方法

    公开(公告)号:US07786291B2

    公开(公告)日:2010-08-31

    申请号:US11259588

    申请日:2005-10-26

    摘要: The invention provides short interfering nucleic acids, either single-stranded or double-stranded, that cause RNAi-induced degradation of mRNA from the Nav1.8 sodium channel gene; to pharmaceutical compositions comprising such short interfering nucleic acids; recombinant vectors comprising such short interfering nucleic acids; a method for inhibiting translation of an mRNA; a method for inhibiting expression of a polypeptide; a method for blocking the membrane potential in a cell; a method for blocking the sodium current in a cell; and a method for inhibiting chronic pain.

    摘要翻译: 本发明提供短链干扰核酸,单链或双链,其导致RNAi诱导的来自Nav1.8钠通道基因的mRNA降解; 涉及包含这种短干扰核酸的药物组合物; 包含这种短干扰核酸的重组载体; 抑制mRNA翻译的方法; 抑制多肽表达的方法; 阻断细胞膜电位的方法; 阻止细胞中钠电流的方法; 和抑制慢性疼痛的方法。

    COMPOSITIONS AND METHODS FOR SHORT INTERFERING NUCLEIC ACID INHIBITION OF Nav 1.8
    4.
    发明申请
    COMPOSITIONS AND METHODS FOR SHORT INTERFERING NUCLEIC ACID INHIBITION OF Nav 1.8 审中-公开
    组合物和方法用于短暂干扰核酸的抑制作用

    公开(公告)号:US20140256787A1

    公开(公告)日:2014-09-11

    申请号:US14258391

    申请日:2014-04-22

    IPC分类号: C12N15/113

    摘要: The invention provides short interfering nucleic acids, either single-stranded or double-stranded, that cause RNAi-induced degradation of mRNA from the Na.sub.v1.8 sodium channel gene; to pharmaceutical compositions comprising such short interfering nucleic acids; recombinant vectors comprising such short interfering nucleic acids; a method for inhibiting translation of an mRNA; a method for inhibiting expression of a polypeptide; a method for blocking the membrane potential in a cell; a method for blocking the sodium current in a cell; and a method for inhibiting chronic pain.

    摘要翻译: 本发明提供短链干扰核酸,单链或双链,其引起RNAi诱导的来自Na.sv1.8钠通道基因的mRNA的降解; 涉及包含这种短干扰核酸的药物组合物; 包含这种短干扰核酸的重组载体; 抑制mRNA翻译的方法; 抑制多肽表达的方法; 阻断细胞膜电位的方法; 阻止细胞中钠电流的方法; 和抑制慢性疼痛的方法。

    Compositions and methods for short interfering nucleic acid inhibition of Nav1.8
    5.
    发明授权
    Compositions and methods for short interfering nucleic acid inhibition of Nav1.8 有权
    Nav1.8短干扰核酸抑制的组成和方法

    公开(公告)号:US08309703B2

    公开(公告)日:2012-11-13

    申请号:US12789564

    申请日:2010-05-28

    摘要: The invention provides short interfering nucleic acids, either single-stranded or double-stranded, that cause RNAi-induced degradation of mRNA from the Nav1.8 sodium channel gene; to pharmaceutical compositions comprising such short interfering nucleic acids; recombinant vectors comprising such short interfering nucleic acids; a method for inhibiting translation of an mRNA; a method for inhibiting expression of a polypeptide; a method for blocking the membrane potential in a cell; a method for blocking the sodium current in a cell; and a method for inhibiting chronic pain.

    摘要翻译: 本发明提供短链干扰核酸,单链或双链,其导致RNAi诱导的来自Nav1.8钠通道基因的mRNA降解; 涉及包含这种短干扰核酸的药物组合物; 包含这种短干扰核酸的重组载体; 抑制mRNA翻译的方法; 抑制多肽表达的方法; 阻断细胞膜电位的方法; 阻止细胞中钠电流的方法; 和抑制慢性疼痛的方法。